HASHKEY GLOBAL PARTNERS WITH VERIFYVASP TO EXPAND GLOBAL TRAVEL RULE COMPLIANCE
Strategic partnership strengthens regulatory compliance across HashKey Global's international exchange network. SINGAPORE,…
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025 16:05 ET | Source: Ocular Therapeutix, Inc. BEDFORD, Mass.,…
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 07, 2025 16:01 ET | Source: Replimune Group Inc WOBURN, Mass.,…
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
March 05, 2025 17:52 ET | Source: Agios Pharmaceuticals, Inc. CAMBRIDGE, Mass.,…
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
March 04, 2025 16:05 ET | Source: Definitive Healthcare Corp. FRAMINGHAM, Mass.,…
Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 28, 2025 16:00 ET | Source: Adverum Biotechnologies, Inc. REDWOOD CITY,…
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 27, 2025 18:00 ET | Source: Skye Bioscience, Inc. SAN DIEGO,…
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2025 17:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Feb.…
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 13, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Feb.…
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today…